hsa-mir-570: Hsa-mir-570 is a microRNA that has been studied in various contexts. It has been included in Taqman MicroRNA assays used for cDNA amplification [PMC5045398]. SNPs in hsa-mir-570 have been found to not affect their cleavage site [PMC3851333]. Additionally, hsa-mir-570 has been used as a TaqMan assay in the study of various genes and microRNAs [PMC6338629]. It has also been found to correlate with certain variants, such as rs4143815, which is associated with hsa-miR-1252, hsa-miR-1253, hsa-miR-539, and hsa-miR-548 [PMC7894801]. Hsa-mir-570 has also been found to be oppositely regulated between certain subgroups [PMC4206873]. In the context of cancer research, it has been identified as a candidate driver microRNA with recurrent copy number gains [PMC4222074]. Furthermore, it has been included in a list of microRNAs associated with poor prognosis in breast cancer [PMC4822961]. Hsa-mir-570 is also part of a miRNA network that is up-regulated in poor prognosis and implicated in the cell cycle [PMC8004706]. In the study of gallbladder cancer patients, gene-gene interactions involving hsa-mir-570 have shown predictive value for susceptibility and treatment response [PMC5223017].